What happens after the breakthrough?
Artificial intelligence is accelerating discovery. Precision medicine is tailoring treatments to ever-smaller patient groups. Gene therapies are redefining what medicine can achieve.
But the next decade may be shaped less by scientific breakthroughs than by the systems needed to develop, govern, finance and deliver them.
Drawing on insights from more than 80 experts, Zurich's latest Beyond 2030 report explores the technologies, risks and strategic choices reshaping life sciences over the decade ahead.Competitive advantage increasingly lies beyond the product, in the systems, partnerships and capabilities that turn innovation into outcomes.
The new health cold war: Who controls the means of making medicine?
Manufacturing capacity, health data, clinical research and advanced technologies are becoming strategic assets. As governments prioritize resilience and security, organizations must navigate a more fragmented and politically complex operating environment.
The innovation stack: Who turns discovery into scale?
AI is accelerating scientific discovery, but evidence generation, manufacturing, regulation and market access remain difficult and expensive. The challenge is no longer simply discovering innovation, but scaling it.
The self-directed patient: Who is responsible for care beyond care?
Healthcare is moving beyond hospitals and clinics. Wearables, predictive analytics and connected devices are giving patients greater control while creating new questions about accountability, trust and decision-making.
The cost of cure: Who can afford the breakthrough?
One-time and potentially curative therapies are challenging healthcare systems built around recurring treatments. New approaches to funding, reimbursement and risk sharing are emerging as a result.
What changes in practice?
Three priorities emerge across all four themes:
Bring constraints forward
Anticipate regulatory, policy and reimbursement challenges earlier in the innovation process.
Secure the bottlenecks that matter
Identify the capabilities, partnerships and dependencies that are critical to long-term success.
Build accountability into product design
Treat governance, liability and lifecycle management as integral parts of innovation.
